SCHRODINGER INC (SDGR) Stock Price, Quote, News and Overview
NASDAQ:SDGR - Nasdaq - US80810D1037 - Common Stock
SDGR Quote and Key Statistics
SCHRODINGER INC
NASDAQ:SDGR (1/21/2025, 8:25:59 PM)
Premarket: 21.56 +0.23 (+1.08%)21.33
+2.33 (+12.26%)
SDGR Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.53% | ||
| ROE | -39.51% | ||
| Debt/Equity | 0 |
SDGR Performance and Technical Analysis
SDGR Ownership and Analysts
SDGR Latest News and Analysis
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
SDGR Makes Bullish Cross Above Critical Moving Average
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SDGR Makes Notable Cross Below Critical Moving Average
Schrödinger to Present at Piper Sandler 36th Annual Healthcare Conference
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
About SDGR
Company Profile
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 867 full-time employees. The company went IPO on 2020-02-06. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment is focused on building a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The firm's pipeline of drug discovery programs includes SGR-1505 (MALT1 Inhibitor), SGR-2921 (CDC7 Inhibitor), SGR-3515 (WEE1 Inhibitor). Its software was used by researchers around the world at more than 1,760 academic institutions.
Company Info
SCHRODINGER INC
1540 Broadway, 24th Floor
New York City NEW YORK 10036 US
CEO: Ramy Farid
Employees: 867
Company Website: https://www.schrodinger.com
Investor Relations: https://ir.schrodinger.com/
Phone: 15032991150
SDGR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 35.69 | 36.21B | ||
| DOCS | DOXIMITY INC-CLASS A | 49.57 | 10.37B | ||
| WAY | WAYSTAR HOLDING CORP | N/A | 6.55B | ||
| CERT | CERTARA INC | 32.33 | 2.03B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 14.72 | 1.80B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.64B | ||
| PHR | PHREESIA INC | N/A | 1.59B | ||
| EVH | EVOLENT HEALTH INC - A | 11.18 | 1.19B | ||
| HSTM | HEALTHSTREAM INC | 49.06 | 969.77M | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 945.39M | ||
| DH | DEFINITIVE HEALTHCARE CORP | 12.97 | 683.46M | ||
| SLP | SIMULATIONS PLUS INC | 56.54 | 636.05M |